Omega Therapeutics Looks To Address Disease By Tuning Genomic Regulators

 
• By Joseph Haas

The newest Flagship spinout says that by drugging insulated genomic domains, it can tune genomic activity without altering DNA to treat and maybe even cure a broad range of diseases.

Binary-code-DNA
Omega hopes to regulate gene expression without altering DNA

More from Start-Ups & SMEs

More from Business